Local system use not correlated with prevention of COVID-19, study reveals

NewsGuard 100/100 Score

Although many pandemics have occurred throughout human history, digital technology enables the development of new tools for dealing with these events. But now, researchers from Japan have found that some of these systems may not be as effective as initially hoped, indicating that we have much to learn about digital infection prevention.

In a study recently published in Environmental Health and Preventive Medicine, researchers from the University of Tsukuba have revealed that despite being associated with some positive health behaviors, use of a local system was not correlated with prevention of COVID-19.

Ibaraki's Amabie-chan is a system designed to limit the spread of COVID-19 in Ibaraki Prefecture, Japan. Like COVID-19 Contact-Confirming Application (COCOA), an international contact tracing app, the success of the system was limited because the number of active users was lower than expected. However, the system may have had a positive effect on health behaviors and attitudes that could limit the spread of infection, something the researchers at the University of Tsukuba aimed to address.

Ibaraki's Amabie-chan registration might have reminded users to take preventive action against infection. Because contact tracing systems are a new technology, we wanted to investigate the factors that make them work so that we can identify areas for improvement."

Assistant Professor Daisuke Hori, First Author

To do this, the researchers conducted an anonymous web-based survey of 347 people at two different workplaces in Tsukuba, Japan. The survey collected participant demographic characteristics as well as infection prevention behaviors, fear of contracting COVID-19, and the use of both Ibaraki's Amabie-chan and COCOA.

"The results were surprising," explains lead investigator Professor Shinichiro Sasahara. "Although the use of Ibaraki's Amabie-chan was associated with COCOA use and with the management of physical condition such as measuring body temperature, we found no association between Ibaraki's Amabie-chan use and fear of COVID-19 or other nine type of behaviors focused on preventing infection".

"Our findings indicate that use of Ibaraki's Amabie-chan was not fully associated with infection control behavior. As such, further investigation is needed to examine the factors that influence the use of this system and behaviors that prevent infection," says Assistant Professor Hori.

Identifying factors that influence effectiveness is critical to improving existing systems or designing new ones that encourage users to adopt safer behaviors. Further studies are needed to understand the factors that make such systems attractive to users, with the goal of preventing the spread of infection. Improving such systems so that they are more cost-effective and easier to use could be crucial in effectively dealing with future pandemics.

Source:
Journal reference:

Hori, D., et al. (2022) Ibaraki’s Amabie-chan usage and its association with infection prevention behavior and fear of COVID-19: a cross-sectional preliminary survey of the Tsukuba Salutogenic Occupational Cohort Study. Environmental Health and Preventive Medicine. doi.org/10.1265/ehpm.22-00052.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study reveals higher mortality risk in COVID-19 patients with newly-diagnosed atrial fibrillation